Percutaneous cryoablation in treatment of liver cancer:a report of 31 cases

钱国军,陈汉,吴孟超

DOI: https://doi.org/10.11569/wcjd.v11.i6.712

2003-01-01

World Chinese Journal of Digestology

Abstract:AIM: To describe the indication, efficacy and clinical significance of percutaneous cryoablation in the treatment of liver malignancy. METHODS: Total 31 patients with histologically or clinically confirmed primary or metastatic malignancies were treated pucutaneously under ultrasound guidance using the cryocare surgical system from July 2001 to January 2002. All patients were followed up to determine the serum tumor marker, and reveal CT scans, MRI images or utra-sound images. RESULTS: This therapy was performed in 31 patients including 26 cases with Child A liver reserve, 4 cases with Child B and 1 cases with Child C. There were 21 cases of primary liver cancer and 10 metastastic liver cancer. AFP positive small liver cancer became AFP negative in 80 % patients. The rate of completely concreted necrosis in small hepatic cancer with negative AFP was 66.7 %, shown by CT or MRI. The curative rate for metastasis liver cancer was 50 % at CT, MRI or tumor marker level. CONCLUSION: Percutaneous cryoablation is a kind of new palliative treatment for liver carcinoma. It is minimally invasive, safe and effective especially for patients with unresectable liver cancer.